Webinar Replay: Generally Recognized as Safe Regulatory Requirements

After publication of the draft Generally Regarded As Safe (GRAS) rule in 1977, the United States Food and Drug Administration (FDA) initiated an Interim Pilot Program encouraging the notification to FDA of GRAS determinations. This presentation analyzes GRAS notifications submitted during the Interim Pilot program along with warning letters issued during the same time period to better understand the evolution of the program and anticipate the future GRAS landscape. This webinar replay expires May 23, 2019.